Evidence map›Paper›PMID 33032616›Full record

ArticleGlobalization and health2020

Lessons learned from COVID-19 for the post-antibiotic future.

Lindsay A Wilson, Susan Rogers Van Katwyk, Patrick Fafard, A M Viens, Steven J Hoffman

Abstract read
In one paragraph

Article in Globalization and health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Prevalence and Antibiotic Resistance Pattern ofAntibiotics (Basel, Switzerland) · 2023
    Article
  3. Resistome Study in Aquatic Environments.Journal of microbiology and biotechnology · 2023
    Review
  4. Article
  5. Deep Learning and Antibiotic Resistance.Antibiotics (Basel, Switzerland) · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Antibiotic Discovery and Resistance: The Chase and the Race.Antibiotics (Basel, Switzerland) · 2022
    Review
  10. Embed Multisectoral Governance Mechanisms in the Pandemic Instrument for One Health Action.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2022
    Article
  11. Article
  12. Review
  13. A Global Pandemic Treaty Must Address Antimicrobial Resistance.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2021
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lindsay A WilsonGlobal Strategy Lab, York University/University of Ottawa, 4700 Keele Street, 2120 Dahdaleh Building, Toronto, ON, M3J 1P3, Canada.
Susan Rogers Van KatwykGlobal Strategy Lab, York University/University of Ottawa, 4700 Keele Street, 2120 Dahdaleh Building, Toronto, ON, M3J 1P3, Canada.
Patrick FafardGlobal Strategy Lab, York University/University of Ottawa, 4700 Keele Street, 2120 Dahdaleh Building, Toronto, ON, M3J 1P3, Canada.
A M ViensGlobal Strategy Lab, York University/University of Ottawa, 4700 Keele Street, 2120 Dahdaleh Building, Toronto, ON, M3J 1P3, Canada.
Steven J HoffmanGlobal Strategy Lab, York University/University of Ottawa, 4700 Keele Street, 2120 Dahdaleh Building, Toronto, ON, M3J 1P3, Canada. steven.hoffman@globalstrategylab.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCOVID-19 has rapidly and radically changed the face of human health and social interaction. As was the case with COVID-19, the world is similarly unprepared to respond to antimicrobial resistance (AMR) and the challenges it will produce. COVID-19 presents an opportunity to examine how the international community might better respond to the growing AMR threat. MAIN BODY: The impacts of COVID-19 have manifested in health system, economic, social, and global political implications. Increasing AMR will also present challenges in these domains. As seen with COVID-19, increasing healthcare usage and resource scarcity may lead to ethical dilemmas about prioritization of care; unemployment and economic downturn may disproportionately impact people in industries reliant on human interaction (especially women); and international cooperation may be compromised as nations strive to minimize outbreaks within their own borders.

conclusionAMR represents a slow-moving disaster that offers a unique opportunity to proactively develop interventions to mitigate its impact. The world's attention is currently rightfully focused on responding to COVID-19, but there is a moral imperative to take stock of lessons learned and opportunities to prepare for the next global health emergency.

Indexed as

Drug Resistance, MicrobialAnti-Bacterial AgentsCoronavirus InfectionsCOVID-19COVID-19 Drug TreatmentDisaster PlanningForecastingGlobal HealthHumansInternational CooperationPandemicsPneumonia, ViralAnti-Bacterial AgentsAntimicrobial resistanceCOVID-19Emergency preparednessInternational cooperation

Identifiers

PMID33032616
PMCPMC7542564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.